Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Fish and Richardson
Johnson and Johnson
Argus Health

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080157

« Back to Dashboard

NDA 080157 describes PYRAZINAMIDE, which is a drug marketed by Akorn and Dava Pharms Inc and is included in two NDAs. It is available from six suppliers. Additional details are available on the PYRAZINAMIDE profile page.

The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
Summary for 080157
Applicant:Dava Pharms Inc
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 080157
Medical Subject Heading (MeSH) Categories for 080157
Suppliers and Packaging for NDA: 080157
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PYRAZINAMIDE pyrazinamide TABLET;ORAL 080157 ANDA A-S Medication Solutions 50090-0521 50090-0521-0 100 TABLET in 1 BOTTLE (50090-0521-0)
PYRAZINAMIDE pyrazinamide TABLET;ORAL 080157 ANDA American Health Packaging 60687-138 60687-138-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-138-01) > 1 TABLET in 1 BLISTER PACK (60687-138-11)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Army
Queensland Health
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.